Chromosomal instability and aneuploidy in cancer: From yeast to man

EMBO Reports

Volumn 13, Issue 6, 2012, Pages 515-527

  Pfau, Sarah J ^a   Amon, Angelika ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

aneuploidy; cancer; Down syndrome; genomic instability; tumorigenesis

Indexed keywords

BUB1 PROTEIN; BUB1 RELATED PROTEIN; BUB3 PROTEIN; CELL CYCLE PROTEIN 20; PROTEIN; PROTEIN MAD2; STROMAL ANTIGEN 1; STROMAL ANTIGEN 2; UNCLASSIFIED DRUG;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ALLELE; ANEUPLOIDY; CANCER MODEL; CANCER THERAPY; CARCINOGENESIS; CELL FUNCTION; CHROMOSOMAL INSTABILITY; DNA DAMAGE; DOWN SYNDROME; FIBROBLAST; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ANEUPLOIDY; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL INSTABILITY; GENE DOSAGE; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS;

EID: 84861880210     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2012.65     Document Type: Review

References (115)

1. Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10: 789-799 (Pubitemid 39070849)
2. Balmain A, Gray J, Ponder B (2003) The genetics and genomics of cancer. Nat Genet 33: 238-244 (Pubitemid 36278834)
3. Longo D (2012) Tumor heterogeneity and personalized medicine. N Engl J Med 366: 956-957
4. Rajagopalan H, Lengauer C (2004) Aneuploidy and cancer. Nature 432: 338-341 (Pubitemid 39551662)
5. Ganem NJ, Storchova Z, Pellman D (2007) Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 17: 157-162 (Pubitemid 46551722)
6. Davidson J, Gorringe K, Chin S, Orsetti B, Besret C, Courtay-Cahen C, Roberts I, Theillet C, Caldas C, Edwards P (2000) Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer 83: 1309-1317
7. Ferti AD, Stamouli MJ, Panani AD, Raptis SA, Young BD (2004) Molecular cytogenetic analysis of breast cancer: a combined multicolor fluorescence in situ hybridization and G-banding study of uncultured tumor cells. Cancer Genet Cytogenet 149: 28-37 (Pubitemid 38177555)
8. Griffin CA, Morsberger L, Hawkins AL, Haddadin M, Patel A, Ried T, Schrock E, Perlman EJ, Jaffee E (2007) Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations. Cytogenet Genome Res 118: 148-156 (Pubitemid 350125251)
9. Geigl JB, Obenauf AC, Schwarzbraun T, Speicher MR (2008) Defining 'chromosomal instability'. Trends Genet 24: 64-69
10. Foijer F, Draviam VM, Sorger PK (2008) Studying chromosome instability in the mouse. Biochim Biophys Acta 1786: 73-82
11. Torres EM, Williams BR, Amon A (2008) Aneuploidy: cells losing their balance. Genetics 179: 737-746
12. Pavelka N, Rancati G, Zhu J, Bradford WD, Saraf A, Florens L, Sanderson BW, Hattem GL, Li R (2010) Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 468: 321-325
13. Upender MB, Habermann JK, McShane LM, Korn EL, Barrett JC, Difilippantonio MJ, Ried T (2004) Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res 64: 6941-6949 (Pubitemid 39331003)
14. Springer M, Weissman JS, Kirschner MW (2010) A general lack of compensation for gene dosage in yeast. Mol Syst Biol 6: 368
15. Reid RJD, Sunjevaric I, Voth WP, Ciccone S, Du W, Olsen AE, Stillman DJ, Rothstein R (2008) Chromosome-scale genetic mapping using a set of 16 conditionally stable Saccharomyces cerevisiae chromosomes. Genetics 180: 1799-1808
16. Birchler JA, Bhadra U, Bhadra MP, Auger DL (2001) Dosage-dependent gene regulation in multicellular eukaryotes: implications for dosage compensation, aneuploid syndromes, and quantitative traits. Dev Biol 234: 275-288 (Pubitemid 32552658)
17. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ, Amon A (2007) Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317: 916-924 (Pubitemid 47301313)
18. Torres EM, Dephoure N, Panneerselvam A, Tucker CM, Whittaker CA, Gygi SP, Dunham MJ, Amon A (2010) Identification of aneuploidy-tolerating mutations. Cell 143: 71-83
19. Williams BR, Prabhu VR, Hunter KE, Glazier CM, Whittaker CA, Housman DE, Amon A (2008) Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322: 703-709
20. Segal DJ, McCoy EE (1974) Studies on Down's syndrome in tissue culture. I. Growth rates protein contents of fibroblast cultures. J Cell Physiol 83: 85-90
21. Fragouli E, Lenzi M, Ross R, Katz-Jaffe M, Schoolcraft WB, Wells D (2008) Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod 23: 2596-2608
22. Tang Y-C, Williams BR, Siegel JJ, Amon A (2011) Identification of aneuploidy-selective antiproliferation compounds. Cell 144: 499-512
23. Thompson SL, Compton DA (2008) Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol 180: 665-672 (Pubitemid 351397764)
24. Thompson SL, Compton DA (2010) Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol 188: 369-381
25. Jeganathan K, Malureanu L, Baker DJ, Abraham SC, van Deursen JM (2007) Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. J Cell Biol 179: 255-267 (Pubitemid 350004890)
26. Li M, Fang X, Baker DJ, Guo L, Gao X, Wei Z, Han S, van Deursen JM, Zhang P (2010) The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc Natl Acad Sci USA 107: 14188-14193
27. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT (2010) ATM activation by oxidative stress. Science 330: 517-521
28. Fang X, Zhang P (2011) Aneuploidy and tumorigenesis. Semin Cell Dev Biol 22: 595-601
29. Burds AA, Lutum AS, Sorger PK (2005) Generating chromosome instability through the simultaneous deletion of Mad2 and p53. Proc Natl Acad Sci USA 102: 11296-11301 (Pubitemid 41153814)
30. Janssen A, van der Burg M, Szuhai K, Kops GJPL, Medema RH (2011) Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333: 1895-1898
31. Ricke RM, Jeganathan KB, van Deursen JM (2011) Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation. J Cell Biol 193: 1049-1064
32. Baker DJ et al (2004) BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 36: 744-749 (Pubitemid 38886637)
33. van Ree JH, Jeganathan KB, Malureanu L, van Deursen JM (2010) Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation. J Cell Biol 188: 83-100
34. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW (2007) Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11: 25-36 (Pubitemid 46070223)
35. Bunz F, Fauth C, Speicher M, Dutriaux A (2002) Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res 62: 1129-1133 (Pubitemid 34160298)
36. Sotillo R, Hernando E, Diaz-Rodriguez E, Teruya-Feldstein J, Cordon-Cardo C, Lowe SW, Benezra R (2007) Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11: 9-23 (Pubitemid 46054519)
37. Babu J, Jeganathan K, Baker D, Wu X, Kang-Decker N, van Deursen J (2003) Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J Cell Biol 160: 341-353 (Pubitemid 36182725)
38. Rehen SK, McConnell MJ, Kaushal D, Kingsbury MA, Yang AH, Chun J (2001) Chromosomal variation in neurons of the developing and adult mammalian nervous system. Proc Natl Acad Sci USA 98: 13361-13366 (Pubitemid 33051368)
39. Rehen SK et al (2005) Constitutional aneuploidy in the normal human brain. J Neurosci 25: 2176-2180 (Pubitemid 40322258)
40. Westra JW, Peterson SE, Yung YC, Mutoh T, Barral S, Chun J (2008) Aneuploid mosaicism in the developing and adult cerebellar cortex. J Comp Neurol 507: 1944-1951 (Pubitemid 351468210)
41. Kingsbury MA, Friedman B, McConnell MJ, Rehen SK, Yang AH, Kaushal D, Chun J (2005) Aneuploid neurons are functionally active and integrated into brain circuitry. Proc Natl Acad Sci USA 102: 6143-6147 (Pubitemid 40594269)
42. Westra JW, Rivera RR, Bushman DM, Yung YC, Peterson SE, Barral S, Chun J (2010) Neuronal DNA content variation (DCV) with regional and individual differences in the human brain. J Comp Neurol 518: 3981-4000
43. Gupta S (2000) Hepatic polyploidy and liver growth control. Semin Cancer Biol 10: 161-171
44. Duncan AW, Hickey RD, Paulk NK, Culberson AJ, Olson SB, Finegold MJ, Grompe M (2009) Ploidy reductions in murine fusion-derived hepatocytes. PLoS Genet 5: e1000385
45. Duncan AW, Taylor MH, Hickey RD, Hanlon Newell AE, Lenzi ML, Olson SB, Finegold MJ, Grompe M (2010) The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 467: 707-710
46. Sheltzer JM et al (2011) Aneuploidy drives genomic instability in yeast. Science 333: 1026-1030
47. Denchi EL, Celli G, de Lange T (2006) Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication. Genes Dev 20: 2648-2653 (Pubitemid 44498375)
48. Wirth KG et al (2006) Separase: a universal trigger for sister chromatid disjunction but not chromosome cycle progression. J Cell Biol 172: 847-860
49. Ganem NJ, Pellman D (2007) Limiting the proliferation of polyploid cells. Cell 131: 437-440 (Pubitemid 350007703)
50. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D (2005) Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437: 1043-1047 (Pubitemid 41486987)
51. Nawata H, Kashino G, Tano K, Daino K, Shimada Y, Kugoh H, Oshimura M, Watanabe M (2011) Dysregulation of gene expression in the artificial human trisomy cells of chromosome 8 associated with transformed cell phenotypes. PLoS ONE 6: e25319
52. Lin H-Y et al (2006) Clinical characteristics and survival of trisomy 18 in a medical center in Taipei, 1988-2004. Am J Med Genet A 140: 945-951
53. Hsu H-F, Hou J-W (2007) Variable expressivity in Patau syndrome is not all related to trisomy 13 mosaicism. Am J Med Genet A 143: 1739-1748 (Pubitemid 47217272)
54. Hassold TJ, Jacobs PA (1984) Trisomy in man. Annu Rev Genet 18: 69-97
55. Roizen NJ, Patterson D (2003) Down's syndrome. Lancet 361: 1281-1289 (Pubitemid 36428586)
56. Glasson EJ, Sullivan SG, Hussain R, Petterson BA, Montgomery PD, Bittles AH (2002) The changing survival profile of people with Down's syndrome: implications for genetic counselling. Clin Genet 62: 390-393 (Pubitemid 36372763)
57. Satge D, Sommelet D, Geneix A, Nishi M, Malet P, Vekemans M (1998) A tumor profile in Down syndrome. Am J Med Genet 78: 207-216 (Pubitemid 28307532)
58. Ganmore I, Smooha G, Izraeli S (2009) Constitutional aneuploidy and cancer predisposition. Hum Mol Genet 18: R84-R93
59. Mitelman F, Heim S, Mandahl N (1990) Trisomy 21 in neoplastic cells. Am J Med Genet Suppl 7: 262-266
60. Cheng Y, Wang H, Wang H, Chen Z, Jin J (2009) Trisomy 21 in patients with acute leukemia. Am J Hematol 84: 193-194
61. Hama A et al (2008) Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome. Br J Haematol 140: 552-561 (Pubitemid 351230083)
62. Sainati L, Leszl A, Surace C, Perilongo G, Rocchi M, Basso G (2002) Fluorescence in situ hybridization improves cytogenetic results in the analysis of hepatoblastoma. Cancer Genet Cytogenet 134: 18-20 (Pubitemid 34462103)
63. Betts DR, Koesters R, Plüss HJ, Niggli FK (1997) Routine karyotyping in Wilms tumor. Cancer Genet Cytogenet 96: 151-156 (Pubitemid 27287490)
64. Korbel J et al (2009) The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci USA 106: 12031-12036
65. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, Davisson MT (1995) A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11: 177-184
66. Minami T et al (2004) Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279: 50537-50554 (Pubitemid 39577872)
67. Ryeom S, Baek K-H, Rioth MJ, Lynch RC, Zaslavsky A, Birsner A, Yoon SS, McKeon F (2008) Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell 13: 420-431 (Pubitemid 351609439)
68. O'Doherty A et al (2005) An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 309: 2033-2037 (Pubitemid 41362316)
69. Baek K-H et al (2009) Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459: 1126-1130
70. Reynolds LE et al (2010) Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome. Nature 465: 813-817
71. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670
72. Sussan TE, Yang A, Li F, Ostrowski MC, Reeves RH (2008) Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature 451: 73-75
73. Yang A, Reeves RH (2011) Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome. Cancer Res 71: 3573-3581
74. Cichowski K, Shih T, Schmitt E, Santiago S, Reilly K, McLaughlin M, Bronson R, Jacks T (1999) Mouse models of tumor development in neurofibromatosis type 1. Science 286: 2172-2176 (Pubitemid 129516295)
75. Vogel KS, Klesse LJ, Velasco-Miguel S, Meyers K, Rushing EJ, Parada LF (1999) Mouse tumor model for neurofibromatosis type 1. Science 286: 2176-2179
76. Hanks S et al (2004) Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36: 1159-1161 (Pubitemid 41288963)
77. Snape K et al (2011) Mutations in CEP57 cause mosaic variegated aneuploidy syndrome. Nat Genet 43: 527-529
78. Plaja A, Vendrell T, Smeets D, Sarret E, Gili T, Català V, Mediano C, Scheres JM (2001) Variegated aneuploidy related to premature centromere division (PCD) is expressed in vivo and is a cancer-prone disease. Am J Med Genet 98: 216-223 (Pubitemid 32118984)
79. Callier P et al (2005) Microcephaly is not mandatory for the diagnosis of mosaic variegated aneuploidy syndrome. Am J Med Genet A 137: 204-207 (Pubitemid 41262689)
80. Plaja A, Perez C, Miró R (2001) Chromosome aneuploidy and cancer: lessons from a chromosomal instability syndrome. Cancer Genet Cytogenet 131: 144-145 (Pubitemid 34003064)
81. Schvartzman J-M, Sotillo R, Benezra R (2010) Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 10: 102-115
82. Solomon DA et al (2011) Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333: 1039-1043
83. Nasmyth K, Haering CH (2009) Cohesin: its roles and mechanisms. Annu Rev Genet 43: 525-558
84. Remeseiro S, Cuadrado A, Carretero M, Martínez P, Drosopoulos WC, Cañamero M, Schildkraut CL, Blasco MA, Losada A (2012) Cohesin-SA1 deficiency drives aneuploidy and tumourigenesis in mice due to impaired replication of telomeres. EMBO J 31: 2090-2102
85. Onn I, Heidinger-Pauli JM, Guacci V, Unal E, Koshland DE (2008) Sister chromatid cohesion: a simple concept with a complex reality. Annu Rev Cell Dev Biol 24: 105-129
86. Musacchio A, Salmon ED (2007) The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8: 379-393 (Pubitemid 46643240)
87. Li M, Fang X, Wei Z, York JP, Zhang P (2009) Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice. J Cell Biol 185: 983-994
88. Michel LS et al (2001) MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409: 355-359 (Pubitemid 32151241)
89. Hernando E et al (2004) Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430: 797-802 (Pubitemid 39071352)
90. Diaz-Rodriguez E, Sotillo R, Schvartzman J-M, Benezra R (2008) Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proc Natl Acad Sci USA 105: 16719-16724
91. Ricke RM, van Ree JH, van Deursen JM (2008) Whole chromosome instability and cancer: a complex relationship. Trends Genet 24: 457-466
92. Sotillo R, Schvartzman J-M, Socci ND, Benezra R (2010) Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 464: 436-440
93. Crasta K et al (2012) DNA breaks and chromosome pulverization from errors in mitosis. Nature 482: 53-58
94. Stephens PJ et al (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144: 27-40
95. Rausch T et al (2012) Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148: 59-71
96. Halazonetis TD, Gorgoulis VG, Bartek J (2008) An oncogene-induced DNA damage model for cancer development. Science 319: 1352-1355 (Pubitemid 351354863)
97. Dunham MJ, Badrane H, Ferea T, Adams J, Brown PO, Rosenzweig F, Botstein D (2002) Characteristic genome rearrangements in experimental evolution of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 99: 16144-16149 (Pubitemid 35462763)
98. Selmecki A, Forche A, Berman J (2006) Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 313: 367-370 (Pubitemid 44480964)
99. Rancati G et al (2008) Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell 135: 879-893
100. Todaro GJ, Green H (1963) Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 17: 299-313
101. Kleihues P, Schäuble B, Hausen zur A, Estève J, Ohgaki H (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 150: 1-13 (Pubitemid 27027090)
102. Stukenberg PT (2004) Triggering p53 after cytokinesis failure. J Cell Biol 165: 607-608
103. Storchova Z, Pellman D (2004) From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5: 45-54 (Pubitemid 38089840)
104. Dalton WB, Yu B, Yang VW (2010) p53 suppresses structural chromosome instability after mitotic arrest in human cells. Oncogene 29: 1929-1940
105. Ozery-Flato M, Linhart C, Trakhtenbrot L, Izraeli S, Shamir R (2011) Large-scale analysis of chromosomal aberrations in cancer karyotypes reveals two distinct paths to aneuploidy. Genome Biol 12: R61
106. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674
107. Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53: 615-627
108. Goss PE, Chambers AF (2010) Does tumour dormancy offer a therapeutic target? Nat Rev Cancer 10: 871-877
109. Druker BJ et al (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344: 1031-1037 (Pubitemid 32267972)
110. Tuveson D, Willis N, Jacks T, Griffin J, Singer S, Fletcher C, Fletcher J, Demetri G (2001) STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications. Oncogene 20: 5054-5058 (Pubitemid 32769795)
111. Baselga J, Norton L, Albanell J, Kim Y, Mendelsohn J (1998) Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res 58: 2825-2831 (Pubitemid 28311914)
112. Knight ZA, Lin H, Shokat KM (2010) Targeting the cancer kinome through polypharmacology. Nat Rev Cancer 10: 130-137
113. Solit DB et al (2008) Phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with metastatic melanoma. Clin Cancer Res 14: 8302-8307
114. Heath EI et al (2008) A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer. Clin Cancer Res 14: 7940-7946
115. Wolman SR, Gundacker H, Appelbaum FR, Slovak ML, Southwest Oncology Group (2002) Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study. Blood 100: 29-35 (Pubitemid 35177424)